Cheyne Capital Management (UK)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Cheyne Capital Management (UK)’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell
2019 Q1	$407K	Hold
2018 Q4	$404K	Sell
2018 Q3	$763K	Hold
2018 Q2	$573K	Hold
2018 Q1	$477K	Buy